• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Axonics Inc (NQ: AXNX )

    70.37 +0.07 (+0.10%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Axonics Inc

    < Previous 1 2 3 4 5 6 7 Next >
    Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
    From Axonics, Inc.
    Via Business Wire
    Axonics Prevails in Patent Infringement Lawsuit with Medtronic
    From Axonics, Inc.
    Via Business Wire
    Axonics Reports Second Quarter 2024 Financial Results
    From Axonics, Inc.
    Via Business Wire
    Beyond The Numbers: 7 Analysts Discuss Axonics Stock
    Via Benzinga
    Analyst Scoreboard: 5 Ratings For Axonics
    Via Benzinga
    Why Axonics Stock Soared Today
    The medical device maker agreed to be acquired by Boston Scientific. 
    Via The Motley Fool
    Health Care Company Boston Scientific Announces Acquisition of Axonics
    Via Benzinga
    7 Robotics Stocks That Could Grow Your Wealth
    Explore robotics stocks with the potential to grow investors' wealth as the industry expands across various sectors. 
    Via InvestorPlace
    Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
    From Axonics, Inc.
    Via Business Wire
    AXNX Stock Earnings: Axonics Misses EPS, Beats Revenue for Q1 2024
    AXNX stock results show that Axonics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Axonics Reports First Quarter 2024 Financial Results
    From Axonics, Inc.
    Via Business Wire
    Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
    Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. 
    Via MarketBeat
    FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
    Boston Scientific announces a Class I recall of Obsidio Embolic due to high-risk implications for lower GI bleeding embolization. Potential adverse effects include bowel ischemia, necessitating major... 
    Via Benzinga
    Exposures Product Safety
    Axonics Stockholders Approve Merger Agreement with Boston Scientific
    From Axonics, Inc.
    Via Business Wire
    Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
    From Axonics, Inc.
    Via Business Wire
    Axonics Responds to ITC Action by Medtronic
    From Axonics, Inc.
    Via Business Wire
    Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
    From Axonics, Inc.
    Via Business Wire
    AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Why Medical Devices Giant Boston Scientific Shares Are Rising Today
    Boston Scientific shares surge in premarket trading following strong Q4 results, beating revenue estimates, amid positive outlook for 2024. 
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
    The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut. 
    Via Investor's Business Daily
    Topics ETFs
    Robinhood, Palo Alto Networks And 2 Other Stocks Insiders Are Selling
    The Nasdaq 100 closed higher by more than 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
    Via Benzinga
    10 Top Stocks With a Strong Buy Rating Right Now
    Wall Street is highly bullish on these strong buy stocks, even as financial markets face an uncertain year. Here are the names to watch. 
    Via InvestorPlace
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... 
    Via Benzinga
    Why Is Crocs (CROX) Stock Up 20% Today?
    Crocs stock is heading higher on Monday with heavy trading of CROX shares after the company posted a strong outlook for 2024! 
    Via InvestorPlace
    Why Is Axonics (AXNX) Stock Up 20% Today?
    Axonics stock is rising higher on Monday as investors react to a $71 per share cash offer for AXNX stock from Boston Scientific. 
    Via InvestorPlace
    Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today?
    Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $7 
    Via Benzinga
    J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value
    The year's biggest medical conference kicked off with a melee of buyout news. 
    Via Investor's Business Daily
    AXNX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Axonics, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.